期刊文献+

Livin阳性乳腺癌中细胞周期调控相关蛋白的变化 被引量:2

Changes of cell cycle control-related proteins in Livin positive breast carcinoma
下载PDF
导出
摘要 目的探讨Livin阳性乳腺癌中细胞周期调控相关蛋白的变化,以初步明确Livin对细胞周期调控相关蛋白的影响。方法采用免疫组化SP法检测Livin在45例乳腺癌中的表达,利用Western blot法检测45例乳腺癌中Cyclin D、Cyclin A、Cyclin E的表达。结果 45例乳腺癌中Livin阳性率为75.56%(34/45)。Livin阳性乳腺癌中,Cyclin A的阳性率为88.23%(30/34),而在Livin阴性乳腺癌中,Cyclin A的阳性率为54.55%(6/11),差异有统计学意义(P<0.05);Livin阳性乳腺癌中,Cyclin D的阳性率为61.76%(21/34),而Livin阴性乳腺癌中,Cyclin D的阳性率为81.82%(9/11),差异无统计学意义(P>0.05);在Livin阳性乳腺癌中,Cyclin E的阳性率为82.35%(28/34),而在Livin阴性乳腺癌中,Cyclin E的阳性率为45.46%(5/11),差异有统计学意义(P<0.05)。乳腺癌组织中Livin与Cyclin A、Cyclin E蛋白表达显著相关(P<0.05)。结论 Livin蛋白在乳腺癌中表达上调,提示其可能在促进乳腺癌发生、发展中起重要作用。Livin表达可导致Cyclin A和Cyclin E表达上调,而对Cyclin D表达作用不明显,提示Livin除了抗细胞凋亡作用外,还可能通过引起细胞周期调控紊乱促进乳腺癌的发生、发展。 Purpose To investigate the changes of cell cycle control-related proteins in Livin-positive breast carcinoma and preliminarily definitize the effects of Livin on the cell cycle control-related proteins in Livin-positive breast carcinoma.Methods Livin was detected by immunohistochemical analysis (IHC,SP method)in 45 breast cancerous tissues.Cyclin D,Cyclin A,Cyclin E were detected in 45 cases of breast cancerous tissues by Western blot.Results Among the 45 breast carcinoma,the positive rate of Livin expression was 75.56% (34/45).In the Livin-positive breast carcinoma,the positive rate of Cyclin A was 88.23% (30/34).But in the Livinnegative breast carcinoma,the positive rate of Cyclin A was 54.55% (6/11).There was a significant difference between the two groups (P <0.05).The positive rate of Cyclin D in the Livin-positive breast carcinoma was 61.76% (21/34),which lower than that in the Livin-negative breast carcinoma (81.82%,9/11),but the difference between the two groups was not statistically significant (P > 0.05).Expression of Cyclin E in the Livin-positive breast carcinoma was 82.35% (28/34),however,in the Livin-negative breast carcinoma,the positive rate of Cyclin E was 45.46% (5/11).There was significant difference between the two groups (P < 0.05).The protein expression of Livin with Cyclin A and Cyclin E were correlated separately (P < 0.05).Conclusions The upregulated expression of Livin is caually linked to the development and progression of the breast carcinoma.The expression of Cyclin A and Cyclin E in Livin-positive breast carcinoma are upregulated,however,the expression of Cyclin D has no dramatic changes.The results show that the disorder of cell cycle control induced by Livin play an important role in the development of breast carcinoma.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2014年第3期248-250,255,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 河南省教育厅自然科学研究计划项目立项课题(12B310011)
关键词 乳腺肿瘤 LIVIN CYCLIN D CYCLIN A CYCLIN E breast neoplasm Livin Cyclin D Cyclin A Cyclin E
  • 相关文献

参考文献4

二级参考文献38

  • 1张华东,袁守军,陈惠鹏,田增月,韩昌明.Livin mRNA的反义核酸诱导MCF-7乳癌细胞凋亡作用(英文)[J].中国临床药理学与治疗学,2004,9(12):1353-1356. 被引量:14
  • 2孙建国,廖荣霞,陈正堂,王志新,张青,胡义德,王东林,粟永萍.Livin异构体特异性siRNA表达载体的构建及其在SPC-A1细胞中的稳定表达[J].肿瘤,2006,26(2):139-143. 被引量:13
  • 3何剪太,李珍发,张阳德,邓丽萍,王吉伟,潘一峰.凋亡抑制因子Livin在大肠癌中的表达意义[J].中国现代医学杂志,2007,17(6):654-657. 被引量:26
  • 4刘海波,陈涛,孔垂泽.凋亡抑制蛋白家族新成员LIVIN的研究进展[J].医学综述,2007,13(7):495-497. 被引量:3
  • 5LIN JH, DENG G, HUANG Q, et al. KIAP, a novel member of the inhibitor of apoptosis protein family [ J ]. Biochem Biophys Res Commun,2000 ,279 (3): 820-831.
  • 6KASOF G M , GOMES B C. Livin , a novel inhibitor of apoptosis protein family member[J].J Biol Chern,2001 ,276 (5) : 3238-3246.
  • 7ASHHAB Y, ALIAN A, POLLIACK A, et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern [ J ]. FEBS Lett, 2001,495 (122) :56450.
  • 8GAZZANIGA P, GRADILONE A, GIULIANI L, et al. Expression and prognostic significance of LIVIN , SURVIVIN and other apoptosis related genes in the progression of superficial bladder cancer[J]. Ann Oncol,2003,14 ( 1 ) :85-90.
  • 9YAGIHASHI A, OHMURA T, ASANUMA K, et al. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer[J]. Clin Chim Acta, 2005, 362(1-2): 125-130.
  • 10TANABE H, YAGIHASHI A, TSUJI N, et al. Expression of surviving mRNA and livin mRNA in non-small-cell lung cancer [ J ]. Lung Cancer, 2004,46 (3) :299-304.

共引文献17

同被引文献13

  • 1Kazuo M,Hiroshi I,Koshi M,et al.Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer.Int J Oncol 2010;36(5):1089-1095.
  • 2Jiang J,Zhu Y,Wu C.Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.Cancer Immunol 2010;59(11):1707-1714.
  • 3Sheedy FJ,Palsson-McDermott E,Hennessy EJ.Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.Nat Immunol 2010;11(2):141-147.
  • 4Heike A.Pdcd4,a colon cancer prognostic that is regulated by a micro RNA.Criti Rev Oncol Hematol 2010;73(3):185-191.
  • 5Stagakis E,Bertsias G,Verginis P,et al.Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis:miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.Ann Rheum Dis 2011;70(8):1496-1506.
  • 6Gao F,Zhang P,Zhou C,et al.Frequent loss of PDCD4 expression in human glioma:possible role in the tumorigenesis of glioma.Oncol Rep 2007;17(1):123-128.
  • 7Sumiya I.Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.World J Surg 2011;35(9):2051-2057.
  • 8Diana B.B7-H4 expression in human melanoma:its association with patients' survival and antitumor immune response.Clin Cancer Res May 2011;15(17):3100.
  • 9Wu HY.B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.Cancer Immunol Immunother 2011;60(7):1047-1055.
  • 10Xue Q,Luan XY,Gu YZ,et al.The negative co-signaling molecule B7-H4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity.Stem Cells Dev 2010;19(1):27-38.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部